Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?

Bartolome Burguera; Khawla F. Ali; Juan P. Brito

doi:10.3949/ccjm.84.s1.05

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?

Bartolome Burguera, Khawla F. Ali, Juan P. Brito

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.

Original language	English (US)
Pages (from-to)	S39-S46
Journal	Cleveland Clinic journal of medicine
Volume	84
Issue number	7
DOIs	https://doi.org/10.3949/ccjm.84.s1.05
State	Published - Jul 1 2017

ASJC Scopus subject areas

General Medicine

Access to Document

10.3949/ccjm.84.s1.05

Cite this

@article{8a05069383774a4ca1df11a28ff3a541,

title = "Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?",

abstract = "Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.",

author = "Bartolome Burguera and Ali, {Khawla F.} and Brito, {Juan P.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2017 Cleveland Clinic.",

year = "2017",

month = jul,

day = "1",

doi = "10.3949/ccjm.84.s1.05",

language = "English (US)",

volume = "84",

pages = "S39--S46",

journal = "Cleveland Clinic journal of medicine",

issn = "0891-1150",

publisher = "Cleveland Clinic Educational Foundation",

number = "7",

}

TY - JOUR

T1 - Antiobesity drugs in the management of type 2 diabetes

T2 - A shift in thinking?

AU - Burguera, Bartolome

AU - Ali, Khawla F.

AU - Brito, Juan P.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.

AB - Antiobesity medications can improve metabolic control for patients with type 2 diabetes mellitus (DM) and obesity, but are underutilized. In this review, we describe the role of antiobesity drugs in the context of medically supervised and comprehensive weight-loss interventions and propose a pragmatic therapeutic algorithm for patients with type 2 DM and obesity that incorporates the use of antiobesity drugs early in the course of management.

UR - http://www.scopus.com/inward/record.url?scp=85052942439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052942439&partnerID=8YFLogxK

U2 - 10.3949/ccjm.84.s1.05

DO - 10.3949/ccjm.84.s1.05

M3 - Review article

C2 - 28708481

AN - SCOPUS:85052942439

SN - 0891-1150

VL - 84

SP - S39-S46

JO - Cleveland Clinic journal of medicine

JF - Cleveland Clinic journal of medicine

IS - 7

ER -

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this